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Boesenbergia rotunda, traditionally used to relieve stomach, abdomen, joint, muscle, and 
rheumatic pain was also reported for its antinociceptive effect on a mouse model. However, 
the possible pain relief effect of Boesenbergia rotunda ethanolic extract (BREE) via the 
inhibition to the neural pain pathway remains to be elucidated. This study investigated the 
inhibitory effect of BREE on compound action potentials (CAPs) and the possible involvement 
of the opioid receptors. The changes in the CAPs amplitudes of the frog’s sciatic nerves were 
evaluated following the exposure to three different dosages of BREE (1, 3 and 10 mg/ml and 
morphine (3 mg/ml). In another set of experiment, the nerves were pretreated with a non-
selective opioid receptor antagonist, naloxone (0.1 mg/ml), before exposing the nerve to BREE 
(1 mg/ml) to investigate the involvement of opioid receptors in the CAPs inhibitory 
mechanism. The outcome showed a reduction in the CAPs amplitudes when treated with BREE 
(1, 3 and 10 mg/ml) whereby the effect was reversible. The CAPs inhibition by BREE was 
absent when the opioid receptors were blocked. Taken together, these findings suggest that 
BREE-induced CAPs amplitude reduction involves the activation of opioid receptors. 
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